Shares of Medical Technology Companies Down After Hours on New Study--Market Mover
May 10 2018 - 7:52PM
Dow Jones News
Shares of Abbott Laboratories, Johnson & Johnson, Medtronic
PLC and Boston Scientific Corp. were down after-hours Thursday
after a new study found an increasingly common cardiovascular
procedure using a device made by several medical technology
companies was no better than drug therapy at preventing deaths,
strokes and certain other complications. The Wall Street Journal
reported late Thursday the outcome of the trial, presented by
researchers at the annual scientific meeting of the Heart Rhythm
Society in Boston, raises questions about the procedure, known as
catheter ablation, to treat patients with atrial fibrillation. The
procedure, meant to stop abnormal electrical signals from causing
irregular heartbeats, involves a doctor inserting a thin tube
through a patient's blood vessels to deliver tiny scars to heart
tissue. Shares of Abbott Laboratories, which makes the device used
in the procedure, fell 1.5% to $59.67. (aisha.al-muslim@wsj.com;
@aishalmuslim)
(END) Dow Jones Newswires
May 10, 2018 19:37 ET (23:37 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024